Immunoglobulin may transiently impair efficacy of live attenuated rubella vaccine due to interference with active antibody response from passively acquired antibodies.
Source: NLP:human immunoglobulin g
3 interactions on record
Immunoglobulin may transiently impair efficacy of live attenuated rubella vaccine due to interference with active antibody response from passively acquired antibodies.
Source: NLP:human immunoglobulin g
VIGIV may impair efficacy of live attenuated rubella vaccine. Defer vaccination until approximately three months after VIGIV administration or revaccinate three months after VIGIV if vaccinated shortly before.
Source: NLP:vaccinia immune globulin intravenous (human)
Live rubella vaccine may temporarily depress PPD reactivity. Tuberculin test should be given before vaccine, simultaneously at separate site, or postponed 4-6 weeks.
Source: NLP:tuberculin purified protein derivative